Form 4: Zymeworks Executive Receives Stock Options and Restricted Stock Units

Zymeworks' EVP & Chief Medical Officer, Jeffrey T.L. Smith, was granted stock options and restricted stock units on January 10, 2025.

Summary

• Jeffrey T.L. Smith, EVP & Chief Medical Officer of Zymeworks Inc., received stock options for 79,000 shares and 53,000 restricted stock units (RSUs) on January 10, 2025.
• The stock options have an exercise price of $13.22 and expire on January 9, 2035.
• The stock options vest over time, with 25% vesting on the first anniversary of the grant date and the remaining 75% vesting in 36 equal monthly installments.
• The RSUs vest in three equal annual installments starting on the first anniversary of the grant date.
• Each RSU represents the right to receive one share of Zymeworks' common stock upon vesting.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management with shareholder interests. There are no negative implications.

Positives

• The grant of stock options and RSUs aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Industry Context

The granting of stock options and restricted stock units is a common practice in the biotechnology industry to incentivize and retain key executives.

Comparison to Industry Standards

• Stock option and RSU grants are standard practice for executive compensation in the biotech industry, often used to align management interests with shareholder value creation.
• Vesting schedules, such as the one described, are typical to ensure long-term commitment from executives.
• The specific terms of the grant, such as the exercise price and vesting period, are generally determined based on the company's performance and industry benchmarks.

Stakeholder Impact

• The grant of stock options and RSUs may have a positive impact on shareholder confidence by aligning executive interests with company performance.

Key Dates

Keywords

stock options, restricted stock units, RSU, executive compensation, insider trading, Zymeworks, ZYME, equity